Skip to main content
. 2022 Jun 29;9:921609. doi: 10.3389/fcvm.2022.921609

Figure 1.

Figure 1

The work flowchart of the study process. Epidemiology, clinical symptoms and current cardioprotective strategies of cancer chemotherapy-induced cardiotoxicity are shown. Our search strategy and main results are also presented. DOX, doxorubicin; FDA, Food and Drug Administration; Top2β, topoisomerase 2β.